Geographic clustering of testicular cancer incidence in the northern part of The Netherlands

D J Sonneveld, M Schaapveld, D T Sleijfer, G J Meerman, W T van der Graaf, R H Sijmons, H S Koops, H J Hoekstra, D J Sonneveld, M Schaapveld, D T Sleijfer, G J Meerman, W T van der Graaf, R H Sijmons, H S Koops, H J Hoekstra

Abstract

Geographic variations in testicular cancer incidence may be caused by differences in environmental factors, genetic factors, or both. In the present study, geographic patterns of age-adjusted testicular cancer incidence rates (IRs) in 12 provinces in The Netherlands in the period 1989-1995 were analysed. In addition, the age-adjusted IR of testicular cancer by degree of urbanization was evaluated. Cancer incidence data were obtained from the Netherlands Cancer Registry. The overall annual age-adjusted IR of testicular cancer in The Netherlands in the period 1989-1995 was 4.4 per 100000 men. The province Groningen in the north of the country showed the highest annual IR with 5.8 per 100000 men, which was higher (P < 0.05) than the overall IR in The Netherlands (incidence rate ratio (IRR) 1.3, 95% confidence interval (CI) 1.1-1.6). The highest IR in Groningen was seen for both seminomas and non-seminomas. In addition, Groningen showed the highest age-specific IRs in all relevant younger age groups (15-29, 30-44 and 45-59 years), illustrating the consistency of data. The province Friesland, also situated in the northern part of the country, showed the second highest IR of testicular cancer with 5.3 cases per 100000 men per year (IRR 1.2, 95% CI 1.0-1.5, not significant). This mainly resulted from the high IR of seminoma in Friesland. Analysis of age-adjusted IRs of testicular cancer by degree of urbanization in The Netherlands showed no urban-rural differences at analysis of all histological types combined, or at separate analyses of seminomas and non-seminomas. Geographic clustering of testicular cancer seems to be present in the rural north of The Netherlands with some stable founder populations, which are likely to share a relatively high frequency of genes from common ancestors including genes possibly related to testicular cancer. Although this finding does not exclude the involvement of shared environmental factors in the aetiology of testicular cancer, it may also lend support to a genetic susceptibility to testicular cancer development. Testicular cancer cases in stable founder populations seem particularly suitable for searching for testicular cancer susceptibility genes because such genes are likely to be more frequent among affected men in such populations.

References

    1. Cancer Epidemiol Biomarkers Prev. 1997 Feb;6(2):141-4
    1. Int J Epidemiol. 1996 Aug;25(4):729-36
    1. N Engl J Med. 1997 Jul 24;337(4):242-53
    1. Eur J Cancer. 1997 Jun;33(7):1075-107
    1. Cancer. 1997 Nov 15;80(10):1954-60
    1. Int J Cancer. 1997 Dec 10;73(6):828-30
    1. Semin Oncol. 1998 Apr;25(2):133-44
    1. Br J Cancer. 1998 Dec;78(11):1401
    1. Eur J Cancer. 1998 Aug;34(9):1363-7
    1. BMJ. 1999 Feb 27;318(7183):559-62
    1. Maandstat Bevolking. 1992 Jul;40(7):14-27
    1. Acta Pathol Microbiol Scand. 1968;72(2):348-9
    1. Cancer. 1969 May;23(5):1119-21
    1. Br J Cancer. 1974 Feb;29(2):176-8
    1. J Natl Cancer Inst. 1977 May;58(5):1255-61
    1. J Natl Cancer Inst. 1979 Aug;63(2):363-6
    1. Natl Cancer Inst Monogr. 1982;62:157-60
    1. Lancet. 1984 Jan 28;1(8370):207-10
    1. Cancer. 1984 Sep 15;54(6):1117-23
    1. Cancer. 1985 Apr 15;55(8):1849-54
    1. Genet Epidemiol. 1984;1(4):383-400
    1. Am J Epidemiol. 1988 Mar;127(3):674-83
    1. Clin Endocrinol (Oxf). 1990 Apr;32(4):519-33
    1. Int J Cancer. 1991 Apr 1;47(6):803-10
    1. J Natl Cancer Inst. 1991 Oct 2;83(19):1391-5
    1. Br J Cancer. 1992 May;65(5):769-71
    1. Lancet. 1993 May 29;341(8857):1392-5
    1. Int J Epidemiol. 1993 Jun;22(3):369-76
    1. Int J Cancer. 1994 Oct 1;59(1):33-8
    1. World J Urol. 1994;12(4):178-81
    1. Hum Mol Genet. 1995 Sep;4(9):1551-5
    1. Eur J Cancer. 1995 Oct;31A(11):1822-9
    1. Clin Exp Allergy. 1995 Nov;25 Suppl 2:97-102
    1. Epidemiol Rev. 1995;17(2):433-49
    1. J Natl Cancer Inst. 1996 Jul 3;88(13):883-9
    1. J Clin Oncol. 1996 Jul;14(7):2061-5
    1. Cancer Epidemiol Biomarkers Prev. 1996 Jan;5(1):3-9
    1. Lancet. 1997 Jan 18;349(9046):160-2

Source: PubMed

3
購読する